Scott P. Bruder

Insider Reports History

Entity
Individual
Location
C/O Bellerophon Therapeutics, 53 Frontage Road, Suite 301, Hampton, NJ
Signature
/s/ Scott P. Bruder
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott P. Bruder:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bellerophon Therapeutics, Inc. Director Stock Options (Right to Buy) 14.6K $45.3K $3.10 Jun 7, 2023 Direct

Insider Reports Filed by Scott P. Bruder

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BLPH Bellerophon Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
BLPH Bellerophon Therapeutics, Inc. Feb 10, 2023 1 $44.1K 4 Feb 14, 2023 Director
BLPH Bellerophon Therapeutics, Inc. Dec 31, 2021 1 $67.7K 4 Jan 4, 2022 Director